| 1 |
任成山，白莉，钱桂生. 慢性阻塞性肺疾病合并肺癌临床特征及新理念[J/CD]. 中华肺部疾病杂志(电子版)，2015, 8(2):137-142.
|
| 2 |
Pirozynski M. 100 years of lung cancer[J]. Respir Med, 2006, 100(12): 2073-2084.
|
| 3 |
Celli BR. Chronic obstructive pulmonary disease and lung cancer: common pathogenesis, shared clinical challenges[J]. Proc Am Thorac Soc, 2012, 9(2): 74-79.
|
| 4 |
Falk RT, Staff AC, Bradwin G, et al. A prospective study of angiogenic markers and postmenopausal breast cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial[J]. Cancer Causes Control, 2016, 27(8): 1009-1017.
|
| 5 |
Buist AS, McBurnie MA, Vollmer WM, et al. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study[J]. Lancet, 2007, 1370(9589): 741-750.
|
| 6 |
Pillai SG, Ge D, Zhu G, et al. A genome-wide association study in chronic obstructive pulmonary disease (COPD): identification of two major susceptibility loci[J]. PLoS Genet, 2009, 5(3): e1000421.
|
| 7 |
Sundar IK, Mullapudi N, Yao H, et al. Rahman I. Lung cancer and its association with chronic obstructive pulmonary disease: update on nexus of epigenetics[J]. Curr Opin Pulm Med, 2011, 17(4): 279-285.
|
| 8 |
Schwartz AG, Wenzlaff AS, Bock CH, et al. Admixture mapping of lung cancer in 1 812 African-Americans[J]. Carcinogenesis, 2011, 32(3): 312-317.
|
| 9 |
Young RP, Hopkins RJ, Whittington CF, et al. Individual and cumulative effects of GWAS susceptibility loci in lung cancer: associations after sub-phenotyping for COPD[J]. PLoS One, 2011, 6(2): e16476.
|
| 10 |
Baylin SB. The cancer epigenome: its origins, contributions to tumorigenesis，and translational implications[J]. Proc Am Thorac Soc, 2012, 9(2): 64-65.
|
| 11 |
Agusti A, Calverley PM, Celli B, et al. Characterisation of COPD heterogeneity in the ECLIPSE cohort[J]. Respir Res, 2010, 11: 122.
|
| 12 |
Houghton AM. The paradox of tumor-associated neutrophils: fueling tumor growth with cytotoxic substances[J]. Cell Cycle, 2010, 9(9): 1732-1737.
|
| 13 |
Singh A，Wu H, Zhang P, et al. Expression of ABCG2 (BCRP) is regulated by Nrf2 in cancer cells that confers side population and chemoresistance phenotype[J]. Mol Cancer Ther, 2010, 9(8): 2365-2376.
|
| 14 |
Boutten A, Goven D, Artaud-Macari E, et al. NRF2 targeting: a promising therapeutic strategy in chronic obstructive pulmonary disease[J]. Trends Mol Med, 2011, 17(7):363-371.
|
| 15 |
Kajstura J, Rota M, Hall SR, et al. Evidence for human lung stem cells[J]. N Engl J Med, 2011, 364(19): 1795-1806.
|
| 16 |
Campisi J. Cellular senescence: putting the paradoxes in perspective[J]. Curr Opin Genet Dev, 2011, 21(1): 107-112.
|
| 17 |
De Keizer PL, Laberge RM, Campisi J. p53: pro-aging or pro-longevity？[J]. Aging (Albany NY), 2010, 2(7): 377-379.
|
| 18 |
Bartels CL, Tsongalis GJ. MicroRNAs: novel biomarkers for human cancer[J]. Ann Biol Clin, 2010, 68(3): 263-272.
|
| 19 |
Mui TS, Man JM, McElhaney JE, et al. Telomere length and chronic obstructive pulmonary disease: evidence of accelerated aging[J]. J Am Geriatr Soc, 2009, 57(12): 2372-2374.
|
| 20 |
Coppe JP, Patil CK, Rodier F, et al. A human-like senescence-associated secretory phenotype is conserved in mouse cells dependent on physiological oxygen[J]. PLoS One, 2010, 5(2): e9188.
|
| 21 |
Yoshida T, Mett I, Bhunia AK, et al. Rtp801, a suppressor of mTOR signaling, is an essential mediator of cigarette smoke-induced pulmonary injury and emphysema[J]. Nat Med, 2010, 16(7): 767-773.
|
| 22 |
Lee CG, Da Silva CA, Dela Cruz CS, et al. Role of chitin and chitinase/chitinase-like proteins in inflammation, tissue remodeling, and injury[J]. Annu Rev Physiol, 2011, 73: 479-501.
|
| 23 |
James AJ, Reinius LE, Verhoek M, et al. Increased YKL-40 and chitotriosidase in asthma and chronic obstructive pulmonary disease[J]. Am J Respir Crit Care Med, 2016, 193(2): 131-142.
|
| 24 |
Atherton JC, Blaser MJ. Coadaptation of Helicobacter pylori and humans: ancient history, modern implications[J]. J Clin Invest, 2009, 119(9): 2475-2487.
|
| 25 |
Kim HJ, Kim YS, Kim KH，et al. The microbiome of the lung and its extracellular vesicles in nonsmokers, healthy smokers and COPD patients[J]. Exp Mol Med, 2017, 49(4): e316.
|
| 26 |
Sapkota AR, Berger S, Vogel TM. Human pathogens abundant in the bacterial metagenome of cigarettes[J]. Environ Health Perspect, 2010, 118(3): 351-356.
|
| 27 |
韩勇，徐辉，王安辉，等. 慢性阻塞性肺疾病是肺癌的危险因素[J]. 第四军医大学学报，2005, 26(2): 146-149.
|
| 28 |
陈亚红. 慢性阻塞性肺疾病与肺癌[J/CD]. 中国医学前沿杂志(电子版), 2014, 6(2): 3-5.
|
| 29 |
吴力旭，刘力兴. 慢性阻塞性肺疾病合并肺癌252例临床分析[J]. 现代预防医学，2010, 37(20): 3992-3993.
|
| 30 |
廖晨，余祖滨，张萍，等. 慢性阻塞性肺疾病合并肺癌122例临床特征分析[J/CD]. 中华肺部疾病杂志(电子版), 2015, 8(1): 30-34.
|